Full access
Erratum
Published Online: 3 March 2006

Erratum

Publication: Psychiatric News
Volume 41, Number 5
https://doi.org/10.1176/pn.41.5.0020
PDF/EPUB
It was incorrectly reported in the January 20 issue that the methylphenidate skin patch was deemed approvable by an FDA panel for the treatment of attention-deficit/hyperactivity disorder in adults as well as children aged 6 to 12. In fact, approval was sought and obtained for use only in children aged 6 to 12. The patch was developed by Noven Pharmaceuticals and will be marketed jointly by Noven and Shire Pharmaceuticals under the trade name Daytrana. ▪

Information & Authors

Information

Published In

Go to Psychiatric News
Psychiatric News
Volume 41 • Number 5 • March 3, 2006
Pages: 20

History

Published online: 3 March 2006
Published in print: March 3, 2006

Authors

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard
Tips for downloading citations

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share

×

As described within the American Psychiatric Association (APA)'s Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences. Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.